Cite
HARVARD Citation
Ma, W. et al. (2020). Cardiotoxicity of sorafenib is mediated through elevation of ROS level and CaMKII activity and dysregulation of calcium homoeostasis. Basic & clinical pharmacology & toxicology. 126 (2), pp. 166-180. [Online].